Moxifloxacin NDC 51407-321

NDC codes

FDA NDC Directory

Product NDC (as listed)51407-321Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51407-0321Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51407-321-03	51407032103	1 BOTTLE, DROPPER in 1 CARTON (51407-321-03) / 3 mL in 1 BOTTLE, DROPPERMarketed from Apr 21, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Moxifloxacin
Generic name (nonproprietary): moxifloxacin
Active ingredients: Moxifloxacin hydrochloride monohydrate — 5 mg/mL
Dosage form: Solution/ drops
Route: Ophthalmic
Labeler: Golden State Medical Supply, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 090080
Marketing start: Jun 30, 2017
Listing expires: Dec 31, 2026
Other FDA classes: Fluoroquinolones (Chemical structure)
Identifiers: Product ID 51407-321_462c4ec2-869f-68a8-e063-6394a90a62f9SPL ID 462c4ec2-869f-68a8-e063-6394a90a62f9SPL set ID f9dff08a-edb2-86de-e053-6394a90a1043RxCUI 403818UNII B8956S8609
Pharmacologic class: Fluoroquinolone Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N451407032103 followed by a unit qualifier and the quantity

Package 51407-0321-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 17, 2025.

Indications (excerpt from the label)

Moxifloxacin ophthalmic solution is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: Corynebacterium species* Micrococcus luteus* Staphylococcus aureus Staphylococcus epidermidis Staphylococcus haemolyticus Staphylococcus hominis Staphylococcus warneri* Streptococcus pneumoniae Streptococcus viridans group Acinetobacter lwoffii* Haemophilus influenza Haemophilus parainfluenzae* Chlamydia trachomatis *Efficacy for this organism was studied in fewer than 10 infections. Moxifloxacin ophthalmic solution is a topical fluoroquinolone anti-infective indicated for the treatment of bacterial conjunctivitis caused by susceptible strains …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 090080

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 090080
Product	Strength	Form · route	Labeler	Product NDC
Moxifloxacin	Moxifloxacin hydrochloride monohydrate 5 mg/mL	Solution/ dropsOphthalmic	Advanced Rx Pharmacy of Tennessee, LLC	80425-0239
Moxifloxacin	Moxifloxacin hydrochloride monohydrate 5 mg/mL	Solution/ dropsOphthalmic	Bryant Ranch Prepack	72162-2107
Moxifloxacin	Moxifloxacin hydrochloride monohydrate 5 mg/mL	Solution/ dropsOphthalmic	Apotex Corp.	60505-0582